Prime Capital Investment Advisors’s Exact Sciences EXAS Stock Holding History

Prime Capital Investment Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,772	Closed	-$279K	–	1028
2023 Q4	$279K	Sell	3,772 -5,084	-57%	-$333K	﹤0.01%	757
2023 Q3	$604K	Sell	8,856 -8,273	-48%	-$702K	0.01%	430
2023 Q2	$1.61M	Sell	17,129 -364	-2%	-$28.4K	0.03%	287
2023 Q1	$1.19M	Buy	+17,493	New	+$1.12M	0.05%	219
2019 Q4	–	Sell	-80	Closed	-$7K	–	597
2019 Q3	$7K	Buy	+80	New	+$9.12K	﹤0.01%	564

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Prime Capital Investment Advisors's EXAS Position: Q1 2024 in Review

Prime Capital Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2024, closing a stake of 3,772 shares — an estimated $279K sold.

Prime Capital Investment Advisors first reported a position in EXAS in Q3 2019 and held it in 5 quarters. The position peaked at $1.61M in Q2 2023. 627 funds tracked by Wall St. Rank hold EXAS as of Q1 2024.

Prime Capital Investment Advisors reported no remaining Exact Sciences position as of Q1 2024 after selling out during the quarter.
Prime Capital Investment Advisors sold 3,772 Exact Sciences shares in Q1 2024, an estimated $279K.
Prime Capital Investment Advisors first reported a position in Exact Sciences in Q3 2019 and held it in 5 quarters.
Prime Capital Investment Advisors's Exact Sciences position peaked at $1.61M in Q2 2023.
627 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2024.

Based on Prime Capital Investment Advisors's 13F filing for Q1 2024, filed 15 May 2024.